AN2 Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:ANTX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計配当金

総資産 92.09 M81.34 M75.83 M67.23 M61.95 M 負債合計 10.24 M8.01 M6.98 M6.86 M8.89 M 純資産合計 81.85 M73.33 M68.84 M60.38 M53.06 M 負債および純資産合計 92.09 M81.34 M75.83 M67.23 M61.95 M 有利子負債合計 ————— 純負債 —————

ニュース

AN2 Therapeutics Stock Cools Off After 90% Rally - AN2 Therapeutics (NASDAQ:ANTX)

AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action? - AN2 Therapeutics (NASDAQ:ANTX)

AN2 Therapeutics raises $40M in private placement

AN2 Therapeutics、真性多血症患者対象のepetraborole第2相試験を計画

AN2 Therapeutics plans phase 2 trial of epetraborole in PV

AN2セラピューティクス、サラ・ウィリアムズを主任会計責任者に任命

AN2 Therapeutics appoints Sarah Williams as principal accounting officer

FDA clears IND for epetraborole trial in mycobacterium abscessus

AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?

Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?

AN2セラピューティクス（ANTX）：CFOのデイ氏が8,883ドル相当の株式を売却

An2 therapeutics (ANTX): cfo Day sells $8883 in shares